MAXIMIZING THE VALUE OF YOUR PATENT PORTFOLIO
M AX I M I ZI N G T H E VALU E OF YOU R PAT EN T P O RT FO L IO
© 2016 ROBINS KAPLAN LLP
81
W H AT I S P I N P O I N T I P ?
IMPROVE PORTFOLIO MANAGEMENT
IDENTIFY KEY ASSETS
Pinpoint IP services use our proprietary, data-driven patent analytics capabilities to provide unique insights into patent portfolios.
LEARN COMPETITIVE INTELLIGENCE
© 2016 ROBINS KAPLAN LLP
82
ROBINS KAPLAN D I F F E R E N T I AT O R S
ENFORCEMENT Trial-borne knowledge focused on enforcing patent portfolios
TECHNICAL
EXPERIENCE 20+ years assisting clients in evaluating and monetizing patent portfolios
Deep experience across a widerange of technologies
RECOGNITION Global recognition for courtroom victories, IP asset monetization, innovation defense
© 2016 ROBINS KAPLAN LLP
83
THROUGH FY2015,
72% OF IPR PETITIONS H AV E B E E N INSTITUTED.
© 2016 ROBINS KAPLAN LLP
84
OF THE IPR PETITIONS T H AT W E R E I N S T I T U T E D AND REACHED A FINAL WRITTEN DECISION
28% (161 OUT OF 575 TRIALS C O M P L E T E D ) H A D AT LEAST ONE CHALLENGED CLAIM SURVIVE.
© 2016 ROBINS KAPLAN LLP
85
KEY CRITERIA
© 2016 ROBINS KAPLAN LLP
• • • • • • • • • • • • • • • • • • • • • •
Size of patent family Assignments Percent of self citations Existence of re-issue certificate “High-velocity” art areas Percent of non-patent references Existence of certificate of correction Number of Independent Claims Years left When Asserted/Awarded Cited References Forward References Office Actions Foreign Counterparts Number of means + function claims Length of Claims Length of Specification Pending continuations in family Re-examination certificate Inventors Percent of forward citations by big companies Number of main classes represented in forward citations Number of main classes represented in cited references
I M PA C T O F T E C H N O L O G Y O N I P R O U T C O M E S Relative Institution Rate by Tech Center, 2012-15 By Proceeding Basis – p-value < 0.01; 99% confidence interval 30% 25% 20% TC
Technology Center Name
1600
Biotech/O Chem
1700
Chem/Mats Eng
2100
Comp Arch/Software
2400
Comp Networks/Multiplexing/Video
2600
Communications
2800
Semiconductors/Electrical/Optical Sys
3600
Transportation/Construction/E-Commerce
3700
ME/Mfg
15% 10% 5% 0%
1600 -5% -10%
2100
2400
3600
2600
3700
2800
1700
-15% -20%
-25% -30%
© 2016 ROBINS KAPLAN LLP
87
I M PA C T O F T E C H N O L O G Y O N I P R O U T C O M E S Relative Survival Rate of at Least 1 Claim by Tech Center, 2012-15 By Proceeding Basis – p-value < 0.01; 99% confidence interval 160%
TC
Technology Center Name
140%
1600
Biotech/O Chem
1700
Chem/Mats Eng
2100
Comp Arch/Software
2400
Comp Networks/Multiplexing/Video
2600
Communications
2800
Semiconductors/Electrical/Optical Sys
3600
Transportation/Construction/E-Commerce
3700
ME/Mfg
120% 100% 80% 60% 40% 20% 0%
1600
2100
3600
1700
2600
2400
2800
3700
-20%
-40% -60% -80% -100%
© 2016 ROBINS KAPLAN LLP
88
I D E N T I F Y I N G P R O M I S I N G N O N - C O R E PAT E N T S Uses data-driven forward citation methodology
TCU 1610--Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs Outlying Forward Citations? Yes
No
FR Citation Frequency (log scale)
Observed Distribution of TCUs Citing TCU 1610 0.0000 0.0000
0.2000
0.4000
0.6000
0.8000
1.0000
1.2000
-0.5000
Establishes forward citation characteristics of peers (blue data)
-1.0000
TCU 1620 -1.5000
-2.0000
TCU 1760
-2.5000
TCU 37D -3.0000
-3.5000
Distance from ’665 Patent
© 2016 ROBINS KAPLAN LLP
89
I D E N T I F Y I N G P R O M I S I N G N O N - C O R E PAT E N T S P AT E N T N U M B E R : 6 , 8 4 1 , 6 6 5
Outlying Forward Citations?
P Yes
No
Unusual Technologies Citing Patent TCU
Title
37D
Medical and Surgical Instruments
37E
Medical Instruments, Diagnostic Equipment, and Treatment Devices
FR Citation Frequency (log scale)
Observed Distribution of the ‘665 Patent 0.0000 0.0000
0.2000
0.4000
0.6000
0.8000
1.0000
1.2000
-0.5000
-1.0000
Identifies unusual forward citation pattern and pinpoints from which technologies atypical pattern originates (red data)
TCU 1620 -1.5000
-2.0000
The ‘665 Patent is in TCU1610: Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
TCU 1760
-2.5000
TCU 37D TCU 37E -3.0000
-3.5000
Distance from ’665 Patent
© 2016 ROBINS KAPLAN LLP
90
C U S T O M I Z A B L E D E S C R I P T I V E A N A LY T I C S Pinpoint IP services use key analytics to help visualize patent portfolios, providing customized results: – Live patent portfolio snapshot of issued patents by tech center and by tech center unit – Portfolio activity over time by patent application year – Identify top companies/competitors citing your patents; analyze by patent number, title and number of times cited during specific timeframe – Identify top “live” patents by percentile of forward citations – Identify promising patent families
© 2016 ROBINS KAPLAN LLP
91
PAT E N T N U M B E R : 6 , 9 2 8 , 4 2 5 Patent Title:
Stats:
System for propagating enrichment between documents
Expiration Date: 12/5/2021 Issue Date: 08/09/2005 Filing Date: 12/5/2001
Abstract: A system provides a plurality of controls for enriching the content of a meta-document. A metadocument includes document content and personalities that describe enrichment themes. The system is adapted to automatically, with user settable constrains, determine whether to propagate enrichment between documents using an interaction history. In addition, the system is adapted to automatically determine, with user settable constraints, the form that markup is to take in the document content.
© 2016 ROBINS KAPLAN LLP
Claimed Priority Date: 08/13/2001
Independent Apparatus Claims: 0 “Means for” or “Step for” Independent Claims: 0 Dependent Claims (total): 19
Office Actions: 5 Independent Claims (total): 4 Independent Method Claims: 4
Family Size (U.S.): 9 Open Continuations: No
FIG. 5 illustrates an electronic identification tag having a specified personality that is affixed or positioned proximate to a physical object. 92
PAT E N T N U M B E R : 6 , 9 2 8 , 4 2 5 Box Plots: Percentage of Patent Compared to the Field
Top 3 Citing Entitiess (# Times):
99th Percentile for Specification Length
1) EMC (7)
1650000
2) Google (5) 3) Microsoft Technology Licensing (2) Exemplary claim term(s) absent from specification (red text):
Claim(s) in which it appears:
…of the identified entitles that exist in…
Claims 1, 14, 18, 21(all independent)
…document accessed that cites a plurality of authorities…
Claim 2-(dependent)
…a symmetry metric with identical…
Claim 2-(dependent)
© 2016 ROBINS KAPLAN LLP
~ ~ 350000 ~ ~
80th Percentile for Cited Refs.
97th Percentile for Forward Refs.
1,654,363 (Max Value In peer group)
1300
455(Max Value In peer group)
320,300 characters
455
~ ~
100
90
~ ~ ~ ~
1280(Max Value In peer group)
88 Forward refs.
21 cited refs.
93
© 2016 ROBINS KAPLAN LLP
81
W H AT I S P I N P O I N T I P ?
IMPROVE PORTFOLIO MANAGEMENT
IDENTIFY KEY ASSETS
Pinpoint IP services use our proprietary, data-driven patent analytics capabilities to provide unique insights into patent portfolios.
LEARN COMPETITIVE INTELLIGENCE
© 2016 ROBINS KAPLAN LLP
82
ROBINS KAPLAN D I F F E R E N T I AT O R S
ENFORCEMENT Trial-borne knowledge focused on enforcing patent portfolios
TECHNICAL
EXPERIENCE 20+ years assisting clients in evaluating and monetizing patent portfolios
Deep experience across a widerange of technologies
RECOGNITION Global recognition for courtroom victories, IP asset monetization, innovation defense
© 2016 ROBINS KAPLAN LLP
83
THROUGH FY2015,
72% OF IPR PETITIONS H AV E B E E N INSTITUTED.
© 2016 ROBINS KAPLAN LLP
84
OF THE IPR PETITIONS T H AT W E R E I N S T I T U T E D AND REACHED A FINAL WRITTEN DECISION
28% (161 OUT OF 575 TRIALS C O M P L E T E D ) H A D AT LEAST ONE CHALLENGED CLAIM SURVIVE.
© 2016 ROBINS KAPLAN LLP
85
KEY CRITERIA
© 2016 ROBINS KAPLAN LLP
• • • • • • • • • • • • • • • • • • • • • •
Size of patent family Assignments Percent of self citations Existence of re-issue certificate “High-velocity” art areas Percent of non-patent references Existence of certificate of correction Number of Independent Claims Years left When Asserted/Awarded Cited References Forward References Office Actions Foreign Counterparts Number of means + function claims Length of Claims Length of Specification Pending continuations in family Re-examination certificate Inventors Percent of forward citations by big companies Number of main classes represented in forward citations Number of main classes represented in cited references
I M PA C T O F T E C H N O L O G Y O N I P R O U T C O M E S Relative Institution Rate by Tech Center, 2012-15 By Proceeding Basis – p-value < 0.01; 99% confidence interval 30% 25% 20% TC
Technology Center Name
1600
Biotech/O Chem
1700
Chem/Mats Eng
2100
Comp Arch/Software
2400
Comp Networks/Multiplexing/Video
2600
Communications
2800
Semiconductors/Electrical/Optical Sys
3600
Transportation/Construction/E-Commerce
3700
ME/Mfg
15% 10% 5% 0%
1600 -5% -10%
2100
2400
3600
2600
3700
2800
1700
-15% -20%
-25% -30%
© 2016 ROBINS KAPLAN LLP
87
I M PA C T O F T E C H N O L O G Y O N I P R O U T C O M E S Relative Survival Rate of at Least 1 Claim by Tech Center, 2012-15 By Proceeding Basis – p-value < 0.01; 99% confidence interval 160%
TC
Technology Center Name
140%
1600
Biotech/O Chem
1700
Chem/Mats Eng
2100
Comp Arch/Software
2400
Comp Networks/Multiplexing/Video
2600
Communications
2800
Semiconductors/Electrical/Optical Sys
3600
Transportation/Construction/E-Commerce
3700
ME/Mfg
120% 100% 80% 60% 40% 20% 0%
1600
2100
3600
1700
2600
2400
2800
3700
-20%
-40% -60% -80% -100%
© 2016 ROBINS KAPLAN LLP
88
I D E N T I F Y I N G P R O M I S I N G N O N - C O R E PAT E N T S Uses data-driven forward citation methodology
TCU 1610--Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs Outlying Forward Citations? Yes
No
FR Citation Frequency (log scale)
Observed Distribution of TCUs Citing TCU 1610 0.0000 0.0000
0.2000
0.4000
0.6000
0.8000
1.0000
1.2000
-0.5000
Establishes forward citation characteristics of peers (blue data)
-1.0000
TCU 1620 -1.5000
-2.0000
TCU 1760
-2.5000
TCU 37D -3.0000
-3.5000
Distance from ’665 Patent
© 2016 ROBINS KAPLAN LLP
89
I D E N T I F Y I N G P R O M I S I N G N O N - C O R E PAT E N T S P AT E N T N U M B E R : 6 , 8 4 1 , 6 6 5
Outlying Forward Citations?
P Yes
No
Unusual Technologies Citing Patent TCU
Title
37D
Medical and Surgical Instruments
37E
Medical Instruments, Diagnostic Equipment, and Treatment Devices
FR Citation Frequency (log scale)
Observed Distribution of the ‘665 Patent 0.0000 0.0000
0.2000
0.4000
0.6000
0.8000
1.0000
1.2000
-0.5000
-1.0000
Identifies unusual forward citation pattern and pinpoints from which technologies atypical pattern originates (red data)
TCU 1620 -1.5000
-2.0000
The ‘665 Patent is in TCU1610: Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
TCU 1760
-2.5000
TCU 37D TCU 37E -3.0000
-3.5000
Distance from ’665 Patent
© 2016 ROBINS KAPLAN LLP
90
C U S T O M I Z A B L E D E S C R I P T I V E A N A LY T I C S Pinpoint IP services use key analytics to help visualize patent portfolios, providing customized results: – Live patent portfolio snapshot of issued patents by tech center and by tech center unit – Portfolio activity over time by patent application year – Identify top companies/competitors citing your patents; analyze by patent number, title and number of times cited during specific timeframe – Identify top “live” patents by percentile of forward citations – Identify promising patent families
© 2016 ROBINS KAPLAN LLP
91
PAT E N T N U M B E R : 6 , 9 2 8 , 4 2 5 Patent Title:
Stats:
System for propagating enrichment between documents
Expiration Date: 12/5/2021 Issue Date: 08/09/2005 Filing Date: 12/5/2001
Abstract: A system provides a plurality of controls for enriching the content of a meta-document. A metadocument includes document content and personalities that describe enrichment themes. The system is adapted to automatically, with user settable constrains, determine whether to propagate enrichment between documents using an interaction history. In addition, the system is adapted to automatically determine, with user settable constraints, the form that markup is to take in the document content.
© 2016 ROBINS KAPLAN LLP
Claimed Priority Date: 08/13/2001
Independent Apparatus Claims: 0 “Means for” or “Step for” Independent Claims: 0 Dependent Claims (total): 19
Office Actions: 5 Independent Claims (total): 4 Independent Method Claims: 4
Family Size (U.S.): 9 Open Continuations: No
FIG. 5 illustrates an electronic identification tag having a specified personality that is affixed or positioned proximate to a physical object. 92
PAT E N T N U M B E R : 6 , 9 2 8 , 4 2 5 Box Plots: Percentage of Patent Compared to the Field
Top 3 Citing Entitiess (# Times):
99th Percentile for Specification Length
1) EMC (7)
1650000
2) Google (5) 3) Microsoft Technology Licensing (2) Exemplary claim term(s) absent from specification (red text):
Claim(s) in which it appears:
…of the identified entitles that exist in…
Claims 1, 14, 18, 21(all independent)
…document accessed that cites a plurality of authorities…
Claim 2-(dependent)
…a symmetry metric with identical…
Claim 2-(dependent)
© 2016 ROBINS KAPLAN LLP
~ ~ 350000 ~ ~
80th Percentile for Cited Refs.
97th Percentile for Forward Refs.
1,654,363 (Max Value In peer group)
1300
455(Max Value In peer group)
320,300 characters
455
~ ~
100
90
~ ~ ~ ~
1280(Max Value In peer group)
88 Forward refs.
21 cited refs.
93
